We are live on ! Find out more
PCSA icon

Processa Pharmaceuticals
PCSA

16 hedge funds and large institutions have $12.2M invested in Processa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

9% more capital invested

Capital invested by funds: $11.2M → $12.2M (+$1M)

0% more funds holding

Funds holding: 16 → 16 (0)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VCA
Verdence Capital Advisors
Maryland
+$506K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$188K
3
State Street
State Street
Massachusetts
+$171K
4
Northern Trust
Northern Trust
Illinois
+$17.1K
5
EIM
Essex Investment Management
Massachusetts
+$10.3K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$444K
2
Citadel Advisors
Citadel Advisors
Florida
-$83K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$71.8K
4
BlackRock
BlackRock
New York
-$3.42K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$3.32M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.2M +$6.83K +2 +0.3%
SCM
3
Solas Capital Management
Connecticut
$1.68M – – –
WVP
4
Worth Venture Partners
New Jersey
$780K – – –
EIM
5
Essex Investment Management
Massachusetts
$637K +$10.3K +3 +2%
VCA
6
Verdence Capital Advisors
Maryland
$632K +$506K +148 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$556K +$188K +55 +73%
Janney Montgomery Scott
8
Janney Montgomery Scott
Pennsylvania
$396K -$71.8K -21 -19%
State Street
9
State Street
Massachusetts
$356K +$171K +50 +152%
CBA
10
Coastal Bridge Advisors
Connecticut
$236K – – –
BlackRock
11
BlackRock
New York
$232K -$3.42K -1 -2%
Northern Trust
12
Northern Trust
Illinois
$132K +$17.1K +5 +19%
VRM
13
Vectors Research Management
New York
$34K – – –
AF
14
Allworth Financial
California
$15K – – –
HWA
15
Heritage Wealth Advisors
Virginia
$8.57K – – –
UBS Group
16
UBS Group
Switzerland
$5K +$3.42K +1 New
Morgan Stanley
17
Morgan Stanley
New York
$1K – – –
Wells Fargo
18
Wells Fargo
California
$1K – – –
Millennium Management
19
Millennium Management
New York
– -$444K -108 Closed
Citadel Advisors
20
Citadel Advisors
Florida
– -$83K -20 Closed

PCSA Hedge Fund Activity: Q3 2021 in Review

16 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Processa Pharmaceuticals (PCSA) for Q3 2021, worth a combined $12.2M — up 9% from $11.2M a quarter earlier.

Fund positioning in PCSA was balanced in Q3 2021: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 2 trimmed.

The largest buyer was Verdence Capital Advisors, opening a new position worth an estimated $506K. The largest seller was Millennium Management, exiting entirely with an estimated $444K sold.

  • 16 institutional investors held Processa Pharmaceuticals (PCSA) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $12.2M of Processa Pharmaceuticals stock for Q3 2021, up 9% quarter-over-quarter.
  • 2 funds opened new Processa Pharmaceuticals positions in Q3 2021 and 2 closed out, a net change of 0 holders.
  • The largest Processa Pharmaceuticals buyer in Q3 2021 was Verdence Capital Advisors, an estimated $506K added.
  • The largest Processa Pharmaceuticals seller in Q3 2021 was Millennium Management, an estimated $444K sold.

Based on aggregated 13F filings for Q3 2021.